Letko, Brosseau & Associates’s Adient ADNT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADNT
HHAM
Letko, Brosseau & Associates's ADNT Position: Q2 2026 in Review
Letko, Brosseau & Associates increased its Adient (ADNT) stake by 2.7% in Q2 2026, buying an estimated $933K and bringing the position to 1,661,072 shares worth $30.5M. The position accounts for 0.45% of the portfolio, ranked #62.
Letko, Brosseau & Associates first reported a position in ADNT in Q4 2016 and has held it in 27 quarters since. The position peaked at $81M in Q1 2021. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.
- Letko, Brosseau & Associates held 1,661,072 shares of Adient worth $30.5M as of Q2 2026.
- Letko, Brosseau & Associates bought 43,666 Adient shares in Q2 2026, an estimated $933K.
- Adient made up 0.45% of Letko, Brosseau & Associates's portfolio in Q2 2026, its #62 holding.
- Letko, Brosseau & Associates first reported a position in Adient in Q4 2016 and has held it in 27 quarters since.
- Letko, Brosseau & Associates's Adient position peaked at $81M in Q1 2021.
- 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.
Based on Letko, Brosseau & Associates's 13F filing for Q2 2026, filed 13 Aug 2026.